Korean J Radiol.  2013 Aug;14(4):626-635. 10.3348/kjr.2013.14.4.626.

Radiofrequency Ablation Combined with Transcatheter Arterial Chemoembolization for the Treatment of Single Hepatocellular Carcinoma of 2 to 5 cm in Diameter: Comparison with Surgical Resection

Affiliations
  • 1Department of Radiology, Chonnam National University Hwasun Hospital, Hwasun 519-763, Korea.
  • 2Department of Radiology, Chonnam National University Medical School, Gwangju 501-757, Korea. kjradsss@dreamwiz.com
  • 3Center for Aging and Geriatrics, Chonnam National University Medical School, Gwangju 501-757, Korea.
  • 4Department of Internal Medicine, Chonnam National University Medical School, Gwangju 501-757, Korea.
  • 5Department of Surgery, Chonnam National University Hwasun Hospital, Hwasun 519-763, Korea.

Abstract


OBJECTIVE
To compare the effectiveness of radiofrequency ablation (RFA) combined with transcatheter arterial chemoembolization (TACE) with surgical resection in patients with a single hepatocellular carcinoma (HCC) ranging from 2 to 5 cm.
MATERIALS AND METHODS
The study participants were enrolled over a period of 29 months and were comprised of 37 patients in a combined therapy group and 47 patients in a surgical resection group. RFA was performed the day after TACE, and surgical resection was performed by open laparotomy. The two groups were compared with respect to the length of hospital stay, rates of major complication, and rates of recurrence-free and overall survival.
RESULTS
Major complications occurred more frequently in the surgical resection group (14.9%) than in the combined therapy group (2.7%). However, there was no statistical significance (p = 0.059). The rates of recurrence-free survival at 1, 2, 3 and 4 years were similar between the combined therapy group (89.2%, 75.2%, 69.4% and 69.4%, respectively) and the surgical resection group (81.8%, 68.5%, 68.5% and 65%, respectively) (p = 0.7962, log-rank test). The overall survival rates at 1, 2, 3 and 4 years were also similar between groups (97.3%, 86.5%, 78.4% and 78.4%, respectively, in the combined therapy group, and 95.7%, 89.4%, 84.3% and 80.3%, respectively, in the surgical resection group) (p = 0.6321, log-rank test).
CONCLUSION
When compared with surgical resection for the treatment of a single HCC ranging from 2 to 5 cm, RFA combined with TACE shows similar results in terms of recurrence-free and overall survival rates.

Keyword

Radiofrequency ablation; Hepatocellular carcinoma; Transcatheter arterial chemoembolization; Combination therapy; Hepatectomy

MeSH Terms

Carcinoma, Hepatocellular/diagnosis/mortality/*therapy
Catheter Ablation/*methods
Chemoembolization, Therapeutic/*methods
Disease-Free Survival
Female
Follow-Up Studies
Humans
Liver Neoplasms/diagnosis/mortality/*therapy
Male
Middle Aged
Neoplasm Recurrence, Local/epidemiology
Neoplasm Staging
Republic of Korea/epidemiology
Retrospective Studies
Survival Rate/trends
Treatment Outcome
Full Text Links
  • KJR
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
    DB Error: unknown error